Wiser Advisor Group’s ImmunityBio IBRX Stock Holding History

Wiser Advisor Group’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.3K	Hold	3,000	–	–	0.03%	123
2026 Q1	$23K	Buy	3,000 +1,000	+50%	+$6.85K	0.03%	122
2025 Q4	$3.96K	Hold	2,000	–	–	﹤0.01%	203
2025 Q3	$4.92K	Buy	+2,000	New	+$5.15K	0.01%	203
2025 Q2	–	Sell	-2,000	Closed	-$6.02K	–	137
2025 Q1	$6.02K	Buy	+2,000	New	+$6.06K	0.01%	200

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wiser Advisor Group's IBRX Position: Q2 2026 in Review

Wiser Advisor Group held its ImmunityBio (IBRX) position steady in Q2 2026 at 3,000 shares worth $26.3K. The position accounts for 0.03% of the portfolio, ranked #123.

Wiser Advisor Group first reported a position in IBRX in Q1 2025 and has held it in 5 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Wiser Advisor Group held 3,000 shares of ImmunityBio worth $26.3K as of Q2 2026.
Wiser Advisor Group left its ImmunityBio share count unchanged in Q2 2026.
ImmunityBio made up 0.03% of Wiser Advisor Group's portfolio in Q2 2026, its #123 holding.
Wiser Advisor Group first reported a position in ImmunityBio in Q1 2025 and has held it in 5 quarters since.
404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Wiser Advisor Group's 13F filing for Q2 2026, filed 17 Aug 2026.